Allarity Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Allarity Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q2 2024.
  • Allarity Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 15M shares, a 80342% increase year-over-year.
  • Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.99M shares, a 29154% increase from 2022.
  • Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6.81K shares, a 99.9% decline from 2021.
  • Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 6.36M shares, a 94.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 15M +15M +80342% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 175K +175K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.99M +1.98M +29154% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 2.47M +2.47M +34497% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 18.6K -102K -84.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 528* -236K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 6.81K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 7.15K -7.75M -99.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 120K -4.9M -97.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 237K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 7.75M +4.03M +108% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 5.02M Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-07
Q3 2020 3.72M Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.